Tolfenamic Acid and Caffeine: A Useful Combination in Migraine
- 1 December 1982
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 2 (4) , 173-177
- https://doi.org/10.1046/j.1468-2982.1982.0204173.x
Abstract
Tolfenamic acid is a potent inhibitor of prostaglandin biosynthesis, which has been proved effective in the treatment of acute migraine attacks. The usefulness of caffeine, metoclopramide and pyridoxine as adjuncts to tolfenamic acid was tested in acute migraine attacks in ten patients. A combination of tolfenamic acid (200 mg) with either caffeine (100 mg), metoclopramide (10 mg) or pyridoxine (300 mg) was given twice to each patient in random order. Thus 60 attacks were treated. The tolfenamic acid-caffeine combination proved the most effective as judged by duration and intensity of attacks, working ability, vigilance, and overall evaluation of the drugs by the patients. Metoclopramide was somewhat better than pyridoxine as an additive.Keywords
This publication has 13 references indexed in Scilit:
- Inflammatory pain, prostaglandin hyperalgesia and the development of peripheral analgesicsTrends in Pharmacological Sciences, 1981
- Tolfenamic Acid and Ergotamine AbuseHeadache: The Journal of Head and Face Pain, 1981
- The Anatomy and Physiology of the Vertebral Nerve in Relation to Cervical MigraineCephalalgia, 1981
- Adverse reactions to drugs—the information lagPublished by Elsevier ,1981
- Anxiety and Muscle Tension as Consequences of Caffeine WithdrawalScience, 1980
- Methylxanthines: possible mechanisms of action in brainTrends in Pharmacological Sciences, 1980
- TOLFENAMIC ACID IS AS EFFECTIVE AS ERGOTAMINE DURING MIGRAINE ATTACKSThe Lancet, 1979
- Potentiation of the Anti-Inflammatory and Analgesic Activity of Aspirin by Caffeine in the RatExperimental Biology and Medicine, 1976
- Inhibition of Prostaglandin Biosynthesis by Tolfenamic Acid in VitroScandinavian Journal of Rheumatology, 1976
- The effect of metoclopramide on the absorption of effervescent aspirin in migraine.British Journal of Clinical Pharmacology, 1975